Skip to main content

Table 4 Patient characteristics stratified by discharge status among AKI patients (n = 508)

From: Epidemiology and short-term outcomes of acute kidney injury among patients in the intensive care unit in Laos: a nationwide multicenter, prospective, and observational study

 Survive (n = 207)Die or AMA (n = 301)P value
Reimbursement  0.02
 Government officer16 (7.7%)15 (5.0%) 
 Out-of-pockets158 (76.3%)259 (86.1%) 
 SS, private insurances33 (15.9%)27 (9.0%) 
Primary diagnosis  0.003
 Infectious diseases22 (10.6%)55 (18.3%)0.02
 Gastrointestinal diseases34 (16.4%)24 (8.0%)0.003
 Neurologic diseases14 (6.8%)37 (12.3%)0.04
Comorbidity   
 HT60 (29.0%)119 (39.5%)0.01
 DM46 (22.2%)114 (37.9%)< 0.001
AKI staging  0.03
 133 (15.9%)26 (8.6%) 
 263 (30.4%)87 (28.9%) 
 3111 (53.6%)188 (62.5%) 
AKI etiology
 Renal hypoperfusion113 (54.6%)128 (42.5%)0.007
APACHE II score15.4 (6.9)20.3 (8.9)< 0.001
Non-renal SOFA score3.4 (2.2)7.0 (3.4)< 0.001
Vasopressors172 (83.1%)219 (72.8%)0.007
Mechanical ventilation14 (6.8%)84 (27.9%)< 0.001
RRT18 (8.7%)8 (2.7%)0.002
Urine output (mL)600 (400, 1000)400 (200, 1000)< 0.001
Diuretics72 (34.8%)38 (12.6%)< 0.001
  1. Data are mean (SD), n (%), or median (Q1, Q3), unless stated otherwise
  2. Showed only the significant parameters
  3. AMA against medical advice, SS social security, HT hypertension, BMI body mass index, DM diabetes mellitus, CKD chronic kidney disease, CAD coronary artery disease, CVD cerebrovascular disease, CA-AKI community-acquired AKI, HA-AKI hospital-acquired AKI, APACHE II Acute Physiology and Chronic Health Evaluation II, SOFA Sequential Organ Failure Assessment, RRT renal replacement therapy